AtaiBeckley (ATAI) Interest Expenses (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Interest Expenses came in at $59.2 million in Q1 2026, up 6477.22% year-on-year from $900000.0 in Q1 2025, and down 21.56% quarter-over-quarter from $75.5 million in Q4 2025.
AtaiBeckley (ATAI) Interest Expenses (2020 - 2026) Analysis & Trends
AtaiBeckley's Interest Expenses history runs 3 years deep, the most recent figure standing at $59.2 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 6477.22% year-over-year to $59.2 million in Q1 2026; TTM through Mar 2026 was $59.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $147.6 million, up 5.81% from the prior year.
- Interest Expenses slipped to $59.2 million in Q1 2026 per ATAI's latest filing, from $75.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $215.7 million in Q3 2021 to a low of -$13000.0 in Q4 2024.
- A 5-year average of $25.5 million and a median of $3.4 million in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses surged 1374.23% in 2025 and jumped 6477.22% in 2026, its largest moves.
- Year by year, Interest Expenses stood at $5.1 million in 2024, then jumped by 1374.23% to $75.5 million in 2025, then dropped by 21.56% to $59.2 million in 2026.
- Per Business Quant, the three latest ATAI Interest Expenses figures stand at $59.2 million (Q1 2026), $75.5 million (Q4 2025), and $900000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | 118.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.20 Mn |
| Mar 31, 2026 | 59.20 Mn |
| Dec 31, 2025 | 75.47 Mn |
| Dec 31, 2025 | 75.47 Mn |
| Sep 30, 2025 | 118.80 Mn |
| Sep 30, 2025 | 118.80 Mn |
| Jun 30, 2025 | 19.50 Mn |
| Jun 30, 2025 | 19.50 Mn |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 5.12 Mn |
| Dec 31, 2024 | 5.12 Mn |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Jun 30, 2024 | 5.10 Mn |